Prestwick Pharmaceuticals News
Most Popular Prestwick Pharmaceuticals Story
FDA OK's first drug for Huntington's disease
The FDA has OK'd Prestwick Pharmaceuticals' Xenazine, a new drug that can be used to moderate the symptoms of Huntington's disease. This is the first drug to be approved for Huntington's, which can Read more...
Latest Headlines
- September 17, 2008
- August 18, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
